Basal subtype of head and neck cancer to define response to EGFR inhibitor treatment.

被引：0
|
作者：
Klinghammer, Konrad Friedrich
Otto, Raik
Raguse, Jan D.
Fichtner, Iduna
Albers, Andreas
Keilholz, Ulrich
Hoffmann, Jens
机构：
[1] Charite, Berlin, Germany
[2] Humboldt Univ, Inst Comp Sci, Berlin, Germany
[3] Charite Univ Med Berlin, Clin Oral & Maxillofacial Surg, Berlin, Germany
[4] EPO, Berlin, Germany
[5] Charite, Dept Hematooncol, Ctr Comprehens Canc, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e17512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17512
引用
收藏
页数：3
相关论文
共 50 条
  • [41] THERMORADIOTHERAPY COMBINED WITH A PROTEOLYSIS INHIBITOR (CONTRICAL) IN THE TREATMENT OF HEAD AND NECK-CANCER
    MIKHALKIN, IA
    IASHVILI, ZG
    BYKOV, VL
    ONCOLOGY, 1993, 50 (05) : 344 - 347
  • [42] Effect of cancer nurse navigators (CNN) on physician engagement in multidisciplinary discussions prior to head and neck cancer treatment.
    Werner, Valerie
    Barry-Weers, Anne
    Weese, James Leighton
    Corsten, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [43] Molecular subtypes of head and neck cancer predict response to cetuximab treatment
    Klinghammer, K.
    Otto, R.
    Raguse, J. D.
    Albers, A.
    Fichtner, I.
    Keilholz, U.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S53 - S53
  • [44] Treatment response with Docetaxel and Paclitaxel in head and neck cancer stem cells
    Galbiatti-Dias, A. L. S.
    Fernandes, G. M. M.
    Nascimento Filho, C. H. V.
    Kawasaki-Oyama, R. S.
    Ferreira, L. A. M.
    Maniglia, J. V.
    Raposo, L. S.
    Biselli-Chicote, P. M.
    Pavarino, E. C.
    Goloni-Bertollo, E. M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 589 - 589
  • [45] Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy
    Bezabeh, T
    Odlum, O
    Nason, R
    Kerr, P
    Sutherland, D
    Patel, R
    Smith, ICP
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2005, 26 (08) : 2108 - 2113
  • [46] Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment
    Gleysteen, John P.
    Duncan, Ryan D.
    Magnuson, J. Scott
    Skipper, Joni B.
    Zinn, Kurt
    Rosenthal, Eben L.
    CANCER BIOLOGY & THERAPY, 2007, 6 (08) : 1181 - 1185
  • [47] Tumour angiogenesis and response in combined modality treatment of head and neck cancer
    Dobrowsky, E
    Lang, S
    Dobrowsky, W
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S105 - S105
  • [48] EGFR Inhibitors for the Treatment of Squamous Cell Carcinoma of the Head and Neck
    Mehra, Ranee
    Cohen, Roger B.
    Harari, Paul M.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (02) : 176 - 184
  • [49] The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications
    Zimmermann, Michel
    Zouhair, Abderrahim
    Azria, David
    Ozsahin, Mahmut
    RADIATION ONCOLOGY, 2006, 1 (1)
  • [50] EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
    Ranee Mehra
    Roger B. Cohen
    Paul M. Harari
    Current Oncology Reports, 2008, 10 : 176 - 184
12345